What is an astrocytoma?

An astrocytoma is a type of brain tumour. Astrocytoma belongs to a group of tumours called gliomas. Astrocytomas are the most common type of glioma. 

A glioma is made up of cells that look similar to glial cells. Glial cells are the supporting cells in the brain or spinal cord. There are different types of glial cells.

An astrocytoma is made up of cells that look like glial cell called astrocytes. This type of tumour can develop in most parts of the brain and sometimes in the spinal cord. Astrocytomas can affect people of any age.

This information is about astrocytoma in adults. The Children’s Cancer and Leukaemia Group has more information on caring for children with cancer, including brain tumours. The The Brain Tumour Charity also has information about brain tumours in children.

Related pages

Symptoms of astrocytoma

The type of symptoms can depend on the size and position of the tumour. They also depend on how slowly or quickly it grows. They may develop suddenly or slowly over months or even years.

Symptoms may happen if a tumour presses on or grows into nearby areas of the brain. This can stop that part of the brain from working normally and cause symptoms. Some symptoms can also happen because the tumour causes a build-up of pressure inside the skull. This is called raised intracranial pressure.

Possible symptoms include:

  • seizures (fits)
  • headaches
  • feeling or being sick
  • difficulty speaking or understanding words
  • memory problems
  • being confused
  • changes in mood and personality
  • weakness in an arm or a leg, or the face
  • problems with movement and balance
  • problems with sight.

The tumour may also cause other symptoms, depending on which part of the brain is affected.

Sometimes, an astrocytoma is found in people who do not have symptoms. It may be discovered on a brain scan performed for a different reason - for example, after an injury.

We have more information about possible symptoms of a brain tumour.

Related pages

Causes of astrocytoma

The causes of astrocytomas are unknown, but research is being done to find out more.

We have more information about risk factors and causes of brain tumours.

Diagnosis of astrocytoma

Your doctors need to find out as much as possible about the type, position and size of the tumour so they can plan your treatment.

You will usually have brain scans to find out the exact position and size of the tumour.

You may first have a brain CT scan first. You also usually have an MRI brain scan.

Having an MRI scan is important as it can give more detailed information. If you are not able to have an MRI scan, your doctor will discuss this with you.

There are different types of MRI scans. You may need to have more than 1 to ensure that your doctors have all of the information they need to make a diagnosis and guide any treatment.

We have more information on the different types of MRI scans used to diagnose brain tumours.

Biopsy

You may also have a biopsy, which involves an operation to take a sample of the tumour to test. Brain tumour biopsies are usually done at the same time as surgery to remove the tumour.

Your doctor may also:

  • shine a light at the back of your eye to check if there is swelling
  • ask you questions to check your reasoning and memory
  • do a physical examination of parts of your nervous system, such as checking the power and feeling in your arms and legs, and the movement of your eyes and face
  • arrange for you to have blood tests to check your general health.

Grading and molecular tests for astrocytomas

A doctor who specialises in examining brain tissue samples called a neuro-pathologist looks at the brain tumour sample under a microscope. This is to find out how fast the tumour is likely to grow (its grade). Tests called molecular tests are also done on the sample to look for genetic changes (mutations) in the tumour cells. Molecular markers may also be called biomarkers.

Your doctor will use information from both the grade and the molecular tests to understand how quickly a tumour might grow and to help them decide on treatment. For example, an astrocytoma that looks low-grade may have genetic changes that mean it behaves more like a high-grade glioma.

Grading of astrocytoma

The grade of a tumour describes how abnormal the cells look under a microscope, which gives an idea of how fast the tumour may grow. Astrocytomas can be low- or high-grade.

Low-grade astrocytoma

Gliomas are divided into 4 grades. Low-grade tumours are graded 1 to 2. A low-grade astrocytoma is usually slow growing. Your doctor may describe a low-grade astrocytoma as 1 one of the following:

  • Grade 1 astrocytomas, for example, a pilocytic astrocytoma. These are often removed with surgery and may not need further treatment.
  • Grade 2 astrocytomas, or low-grade diffuse astrocytomas. These are more likely to come back after treatment than a grade 1. They may develop into higher-grade tumours at a later stage. This is called malignant (cancerous) transformation.

High-grade astrocytoma

High grade tumours are graded 3 to 4. A high-grade astrocytoma is more likely to grow quickly. It is common for this tumour to come back after treatment. Further treatment is often needed. Your doctor may describe a high-grade astrocytoma as 1 of the following:

  • Grade 3 astrocytoma, or an anaplastic astrocytoma.
  • Grade 4 astrocytoma (IDH mutant).
  • Grade 4 glioblastomas – GBM (IDH wild type).

Molecular marker (biomarker) tests

Molecular marker tests are done on samples removed from the tumour during surgery. They are also called biomarker tests. Molecular markers describe markers, proteins, or changes in the genetic structure of a tumour. The samples are tested for changes in the genes in the tumour cells. This change is called a gene mutation.

Molecular tests can give doctors more information to help:

  • confirm a diagnosis
  • find out the type of brain tumour
  • know how the tumour may behave in the future
  • understand which treatment is likely to be the most effective.

Some of the most common genetic changes looked for in an astrocytoma are called:

  • IDH mutation
  • 1p/19q codeletion
  • ATRX mutation.

If there is a change in the IDH gene, it is called a IDH mutation. If there is no change, it is called IDH wildtype.

A change in the ATRX gene is a called a ATRX mutation.

Genes are organised into structures called chromosomes. When doctors test the 1p/19q gene, they are testing whether part of chromosomes 1 and 19 is missing in the tumour cells. If there is, this is called 1p/19q co-deletion. This is needed to help confirm a diagnosis of a different type of glioma called an oligodendroglioma.

Grade 4 tumours are also tested for MGMT methylation status. This may be described as methylated or unmethylated. This test helps your doctor decide how effective chemotherapy treatment might be.

Depending on these results, further molecular tests may be done on the same sample to look for other gene changes. The tests may be done with a technology called Next Generation Sequencing (NGS) or Whole Genome Sequencing (WGS). In some cases, different results in molecular markers may change the type of treatment you are offered. Or it may mean you are able to join a particular clinical trial.

You may have to wait some time for the results of these tests. Your doctor can tell you more about molecular tests and whether they might be helpful in your situation.

Treatment for an astrocytoma

Treatments used for an astrocytoma include surgery, radiotherapy and chemotherapy.  You may have a combination of treatments. Your treatment may depend on the:

  • the size and position of the tumour
  • the grade of the tumour
  • molecular marker results
  • symptoms you have.

A team of specialists will plan your treatment. Your specialist doctor and specialist nurse will explain the aims of your treatment and what it involves. They will talk to you about the benefits and risks of different treatment types. They will also explain the side effects.

You may be given a choice of treatment options. You will have time to talk about this with your family, friends and hospital team before you make any treatment decisions.

You will need to give permission (consent) for the hospital staff to give you the treatment. Tell your doctor if you need more information or more time to decide on a treatment.

Surgery

If you need treatment, you usually have surgery to remove the tumour. If you have a low-grade tumour, this may be the only treatment you need.

The surgeon will remove as much of the tumour as possible. Depending on the size and position of the tumour, it may not be possible to remove all the tumour. Your surgeon will discuss this with you and whether you might need further treatment after surgery.

If surgery is not possible, your doctor will talk to you about other treatments.

Further treatment

After surgery, the MDT (multidisciplinary team) will discuss whether further treatment might be recommended. This may be radiotherapy, chemotherapy, or both. You may be referred to a doctor who specialises in cancer treatment called an oncologist. They will talk to you about the benefits and possible side effects of the treatment.

Further treatment after surgery will depend on:

  • how much of the tumour it was possible to remove
  • the grade and molecular markers
  • your symptoms
  • your general health.

The aim of further treatment is to delay or reduce the risk of the astrocytoma coming back after surgery. It also aims to delay or reduce the risk of a low-grade tumour developing into a higher-grade tumour (malignant or cancerous transformation).

Active monitoring (active surveillance)

If diagnostic brain scans suggest the tumour is low-grade and not causing you problems, your doctor may suggest active monitoring. This is also called active surveillance or watch and wait. Active monitoring means regularly checking the tumour with follow-up MRI brain scans to find out if it is growing or changing. Your doctor will also monitor your symptoms carefully.

Some people may have active monitoring before they have any treatment. This means you have active monitoring instead of having treatment straight away.

If you have not had a biopsy, your doctor may also suggest having a biopsy to confirm the diagnosis. A biopsy is an operation to remove a small piece of the tumour.

If you have surgery, your doctor may also suggest active monitoring after surgery, instead of having immediate further treatment. This means delaying treatment until it is needed.

Delaying treatment might be beneficial in some situations because treatment can cause side effects. Some of these side effects may be permanent. Instead of starting treatment straight away, you may see your specialist doctor regularly to discuss the results of your scans. The scan results help your doctor know if and when to recommend treatment.

High-grade tumours grow more quickly and usually need to be treated straight away.

Active monitoring after surgery

You may be offered active monitoring after surgery. This will depend on the grade of the tumour and how much was removed with surgery.

You have regular scans to check if the tumour is growing again and delay having further treatment until it is needed. This might be if you have a low-grade astrocytoma. It will also depend on the molecular markers and your age.

You may find it difficult to cope with the uncertainty of active monitoring and not having treatment. Your specialist nurse can give you support and advice on coping. You might find it helpful to talk about how you feel with family and friends. Or you may want to talk to people who are in a similar situation. You could try joining a support group or online forum.

Radiotherapy and chemotherapy

Radiotherapy uses high-energy X-rays to control or destroy the tumour cells that could not be removed at the time of surgery. Chemotherapy uses anti-cancer drugs to destroy tumour cells.

If you have a low-grade astrocytoma, you may have radiotherapy followed by chemotherapy. Or you may have radiotherapy alone. Occasionally you may have chemotherapy alone.

If you have a high-grade astrocytoma, you will usually have both radiotherapy and chemotherapy, or both. Chemotherapy may be given at the same time as radiotherapy, after radiotherapy, or on its own.

If you have chemotherapy, you may have 1 of the following treatments:

  • temozolomide
  • PCV – this is a combination of procarbazine CCNU (lomustine) and vincristine.

The chemotherapy used will depend on the molecular markers found and your response to treatment. Sometimes you will change chemotherapy depending on how well it is working.

If surgery to remove most or all of the tumour is not possible, you may have radiotherapy, chemotherapy or both. Your doctor will talk to you about your treatment options.

Other drug treatments

Other types of drug treatments including immunotherapy and targeted treatments are not routinely used for brain tumours. Currently they have not shown to be effective enough. Depending on your situation, there may be a clinical trial you could join. If you have questions about this, talk to your doctor.

Side effects of treatment for astrocytoma

Your specialist doctor or specialist nurse will explain your treatment and possible side effects. Most side effects are short-term and will improve gradually when the treatment is over. Some treatments can cause side effects that can continue and may not get better. These are called long-term effects. You may also get side effects that start months or years later. These are called late effects.

We have more information about coping:

When chemotherapy is given at the same time as radiotherapy, it can cause more side effects than either of the treatments alone.

Treatment for symptoms of astrocytoma

You may need treatment for the symptoms of an astrocytoma before you have any treatment for the tumour. You may also need your symptoms managed during your main treatment or after it has finished.

You may have 1 of the following treatments:

  • Drugs called anti-convulsants, also called anti-epileptic drugs (AEDs), to reduce the risk of having seizures.
  • Steroids to reduce swelling around the tumour.
  • Surgery to drain fluid from the brain to another area of the body to reduce pressure inside the skull. This might be with an operation called endoscopic third ventriculostomy (ETV). It involves putting a thin tube called an endoscope into the brain. This helps create a new channel to bypass the blockage of the cerebrospinal fluid (CSF).

Sometimes a brain tumour cannot be removed or may stop responding to treatment. If this happens, you can still have treatment for any symptoms. You will have supportive care (sometimes called palliative care) from a specialist doctor or nurse who is an expert at managing symptoms and giving emotional support.

We have more information about coping with advanced cancer.

Clinical trials

Clinical trials are a type of medical research involving people. They are important because they show which treatments are most effective and safe. This helps healthcare teams plan the best treatment for the people they care for.

Trials may test how effective a new treatment is compared to the current treatment used. Or they may get information about the safety and side effects of treatments.

They will give you information about the clinical trial so that you understand what it means to take part. If you decide not to take part in a trial, your specialist doctor and nurse will respect your decision. You do not have to give a reason for not taking part. Your decision will not change your care. Your doctor will give you the standard treatment for the type of tumour you have.

Clinical trials also research other areas. These include diagnosis and managing side effects or symptoms. As these tumours are rare, there may not always be a relevant clinical trial happening. If there is, your doctor or nurse may ask you to think about taking part.

We have more information about clinical trials.

After your treatment

After your treatment has finished, you will have regular check-ups, tests and scans. How often you are seen and for how long may vary depending on the size and grade of the tumour, the biomarkers found and what treatment you have had. Appointments are usually more frequent to begin with.

You may continue to have some side effects from treatment. These may include tiredness, or problems with processing thoughts and ideas.

Some side effects can start months or years after treatment has finished. You can use your follow-up appointments to talk about these side effects, or about any other worries or problems you have. Your doctor or nurse may refer you to a neurological rehabilitation (neuro-rehab) service. This service may be able to refer you to a physiotherapist, speech and language therapist or occupational therapist and offer emotional support.

If you have any symptoms or side effects you are worried about, you can also contact your doctor or nurse between appointments.

Many people find they get anxious before appointments. This is natural. It may help to get support from family, friends or a specialist nurse.

How diagnosis affects your right to drive

Following diagnosis and treatment for a brain tumour, most people will not be allowed to drive for a period of time. If you drive, it is important to discuss with your doctor how your diagnosis and treatment for a brain tumour affects your right to drive.

If you have a driving licence, you must tell the licencing agency (DVLA or DVA) that you have been diagnosed with a brain tumour. We have more information about how a brain tumour may affect your right to drive.

Getting support

Being diagnosed with a brain tumour may cause a range of different emotions. There is no right or wrong way to feel. It may help to get support from family, friends or a support organisation.

Macmillan is also here to support you. If you would like to talk, you can:

Other organisations who can help

You may also want to get support from a brain tumour charity, such as:

About our information

This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer.

Professor Catherine McBain, Consultant Clinical Oncologist & Honorary Professor in Cancer Sciences

Professor Catherine McBain

Reviewer

Consultant Clinical Oncologist

Date reviewed

Reviewed: 01 May 2024
|
Next review: 01 May 2027
Trusted Information Creator - Patient Information Forum
Trusted Information Creator - Patient Information Forum

Our cancer information meets the PIF TICK quality mark.

This means it is easy to use, up-to-date and based on the latest evidence. Learn more about how we produce our information.

The language we use


We want everyone affected by cancer to feel our information is written for them.


We want our information to be as clear as possible. To do this, we try to:

  • use plain English
  • explain medical words
  • use short sentences
  • use illustrations to explain text
  • structure the information clearly
  • make sure important points are clear.

We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected.


You can read more about how we produce our information here.